KK Women's and Children's Hospital

kkh.com.sg

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

133

Active

48

Phase 3

15

Total enrollment

87,968

Pipeline matrix

Showing 15 of 15 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Letrozole2
Mifepristone1
Fentanyl3
Ropivacaine3
Morphine2
Entonox1
Meperidine1
Ultiva1
Folinic Acid1
Bu Shen Yi Jing Pill1
Anti-CD19 CAR T-cells1
Benzydamine Hydrochloride1
Phenylephrine3
Ephedrine3
Glycerin Suppository1

Next readouts

  • 2017-05-30
  • 2019-05-06
  • 2021-07-19
  • 2024-12-31
  • 2025-08
  • 2025-12
  • 2025-12
  • 2025-12-31
  • 2025-12-31
  • 2025-12-31

Top conditions

  • Metabolic Disease6
  • Anxiety6
  • Pregnancy5
  • Gestational Diabetes5
  • Pain5
  • Anesthesia4
  • Heart Rate3
  • Breast Cancer3

Frequently asked questions about KK Women's and Children's Hospital

How many clinical trials does KK Women's and Children's Hospital have on ClinicalTrials.gov?
KK Women's and Children's Hospital is listed as the lead sponsor on 133 clinical trials in ClinicalTrials.gov, 48 of which are currently active (recruiting, enrolling, or ongoing).
How many of KK Women's and Children's Hospital's trials are in Phase 3?
15 of KK Women's and Children's Hospital's trials are in Phase 3, spread across 15 active drug programs.
What therapeutic areas does KK Women's and Children's Hospital focus on?
KK Women's and Children's Hospital's most-studied conditions on ClinicalTrials.gov are Metabolic Disease, Anxiety, Pregnancy, Gestational Diabetes, Pain.
When are KK Women's and Children's Hospital's next clinical trial readouts?
KK Women's and Children's Hospital has 10 upcoming primary-completion readouts tracked here; the soonest is “Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia”, expected around 2017-05-30.